KONE.F Stock Overview
KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Wellbeing Digital Sciences Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.000001 |
52 Week High | CA$0.019 |
52 Week Low | CA$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | -99.99% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
KONE.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 1.5% | 1.6% |
1Y | -100.0% | 6.6% | 26.1% |
Return vs Industry: KONE.F underperformed the US Healthcare industry which returned 6.6% over the past year.
Return vs Market: KONE.F underperformed the US Market which returned 26.1% over the past year.
Price Volatility
KONE.F volatility | |
---|---|
KONE.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.1% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: KONE.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KONE.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2017 | n/a | Najla Guthrie | www.ketamine.one |
KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada.
Wellbeing Digital Sciences Inc. Fundamentals Summary
KONE.F fundamental statistics | |
---|---|
Market cap | US$1.79m |
Earnings (TTM) | -US$25.21m |
Revenue (TTM) | US$6.44m |
0.0x
P/S Ratio0.0x
P/E RatioIs KONE.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KONE.F income statement (TTM) | |
---|---|
Revenue | CA$6.44m |
Cost of Revenue | CA$6.02m |
Gross Profit | CA$424.24k |
Other Expenses | CA$25.63m |
Earnings | -CA$25.21m |
Last Reported Earnings
Jul 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did KONE.F perform over the long term?
See historical performance and comparison